Retrospective cohort study on the safety and efficacy of panitumumab (Pmab) for patients with metastatic colorectal cancer (mCRC): The HGCSG1002 study—Analysis of clinical early predictor for the efficacy.
Susumu Sogabe
No relevant relationships to disclose
Hiraku Fukushima
No relevant relationships to disclose
Satoshi Yuki
No relevant relationships to disclose
Yoshimitsu Kobayashi
No relevant relationships to disclose
Takuto Miyagishima
No relevant relationships to disclose
Hiroyuki Okuda
No relevant relationships to disclose
Takaya Kusumi
No relevant relationships to disclose
Ayako Doi
No relevant relationships to disclose
Yasushi Tsuji
No relevant relationships to disclose
Yasuyuki Kawamoto
No relevant relationships to disclose
Nobuyuki Ehira
No relevant relationships to disclose
Masahiko Koike
No relevant relationships to disclose
Takashi Meguro
No relevant relationships to disclose
Yasuo Takahashi
No relevant relationships to disclose
Koji Yoshizaki
No relevant relationships to disclose
Shuichi Muto
No relevant relationships to disclose
Atsushi Ishiguro
No relevant relationships to disclose
Sosuke Kato
No relevant relationships to disclose
Yuh Sakata
Research Funding - Bristol-Myers Squibb; Daiichi Sankyo; Merck Serono; Otsuka; Taiho Pharmaceutical; Yakult Honsha
Yoshito Komatsu
Research Funding - Chugai Pharma; Daiichi Sankyo; GlaxoSmithKline; Novartis; Pfizer; Taiho Pharmaceutical; Yakult Honsha